Targeting the reorganization of F-actin for cell-based implantation cartilage repair therapies
Differentiation · 2025
DOI: 10.1016/j.diff.2025.100847 ↗At a glance
Übersichtsarbeit in Differentiation, 2025. Written by Alissa T Rzepski and 5 co-authors. Institution: Department of Biological Sciences, University of Delaware, Newark, DE, USA. Major MEDLINE topics: Cartilage, Connective Tissue Diseases, Actins, Musculoskeletal Diseases. Cited 8 times so far (Crossref); 118 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, National Institutes of Health, NIH National Institute of General Medical Sciences.
Abstract (original language)
Articular cartilage is an avascular tissue that allows for frictionless mobility of joints. Unfortunately, cartilage is incapable of self-repair and any damage leads to degradation in osteoarthritis (OA). Autologous chondrocyte implantation therapies are currently being used to treat focal cartilage defects caused by post-traumatic OA (PTOA). For chondrocyte implantation, chondrocytes are isolated from healthy regions of cartilage from damaged joints, expanded on stiff polystyrene to increase cell number, and reimplanted into damaged areas to stimulate repair. Unfortunately, chondrocyte implantations can ultimately fail as chondrocytes dedifferentiate during expansion. In dedifferentiation, chondrocytes increase in size, elongate, and express contractile cytoskeletal molecules. Furthermore, cells produce a fibroblastic matrix which is biomechanically inferior to articular cartilage matrix. Therefore, developing a greater understanding of dedifferentiation is imperative. In the dedifferentiation process, cellular actin filaments reorganize from a cortical organization into stress fibers. The formation of stress fibers plays a crucial role in chondrocyte dedifferentiation by regulating chondrocyte cell morphology and gene expression. Determining the actin-based molecular underpinnings in chondrocyte dedifferentiation may enable the specific targeting of stress fibers to promote redifferentiation of passaged cells and improve chondrocyte implantation outcomes. This review focuses on how targeting regulators of actin filament organization may promote the redifferentiation of expanded chondrocytes for implantation, thus increasing potential therapeuticlongevity.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biological Sciences, University of Delaware, Newark, DE, USA.
- Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
- Department of Orthopedics, Nemours Children's Hospital, Wilmington, DE, USA; Department of Biomedical Engineering, University of Delaware, Newark, DE, USA.
- Department of Biological Sciences, University of Delaware, Newark, DE, USA; Department of Biomedical Engineering, University of Delaware, Newark, DE, USA. Electronic address: jparreno@udel.edu.
Funding
- NIGMS NIH HHS
- National Institutes of Health
- NIH National Institute of General Medical Sciences
Cite
APA
Rzepski, A. T., Schofield, M. M., Richardson-Solorzano, S., Arranguez, M. L., Su, A. W., & Parreno, J. (2025). Targeting the reorganization of F-actin for cell-based implantation cartilage repair therapies. Differentiation. https://doi.org/10.1016/j.diff.2025.100847
Vancouver
Rzepski AT, Schofield MM, Richardson-Solorzano S, Arranguez ML, Su AW, Parreno J. Targeting the reorganization of F-actin for cell-based implantation cartilage repair therapies. Differentiation. 2025. doi:10.1016/j.diff.2025.100847
BibTeX
@article{Rzepski2025,
author = {Rzepski, Alissa T and Schofield, Mandy M and Richardson-Solorzano, Stephanie and Arranguez, Mark L and Su, Alvin W and Parreno, Justin},
title = {Targeting the reorganization of F-actin for cell-based implantation cartilage repair therapies},
journal = {Differentiation},
year = {2025},
doi = {10.1016/j.diff.2025.100847}
}
EUVIMED